Pilar Font
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Unveiling Endotypes in Systemic Lupus Erythematosus Through Multi-Omic Analysis: Insights into Cardiovascular and Renal Complications.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 01, 2025
Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 15, 2023
Treatment of neovascular age-related macular degeneration within 48 h from diagnosis improves long-term functional outcome.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 09, 2022
Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
Journal: Pharmacology research & perspectives
Published: October 18, 2021
Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: July 29, 2021
Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.
Journal: Frontiers in immunology
Published: July 20, 2021
Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
Journal: Annals of the rheumatic diseases
Published: March 08, 2021
Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.
Journal: Frontiers in immunology
Published: November 20, 2020
Correction to: Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.
Journal: Arthritis research & therapy
Published: June 13, 2020
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.
Journal: Therapeutic advances in chronic disease
Published: May 14, 2020
Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA.
Journal: Joint bone spine
Published: January 21, 2020
Last Updated: 09/26/2026